Takeda's $600 Million Insilico Deal Puts Alex Zhavoronkov's AI Platform Deeper Into Big Pharma
The proposed pact gives Takeda worldwide rights to AI-discovered drug candidates while leaving most of the economics tied to milestones.
点赞
收藏
点踩
分享评论
?
参与讨论
The proposed pact gives Takeda worldwide rights to AI-discovered drug candidates while leaving most of the economics tied to milestones.